Experimental lymphoma pill shows promise but trial halted early
Disease control
Terminated
This early-stage study tested an oral drug called HMPL-523 in 69 adults with lymphoma that had returned or stopped responding to standard treatments. The goal was to check the drug's safety and find the right dose. The trial was stopped early, but researchers looked at side effec…
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC